BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 1884478)

  • 1. Positron emission tomography for the assessment of myocardial viability.
    Schelbert HR
    Circulation; 1991 Sep; 84(3 Suppl):I122-31. PubMed ID: 1884478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Scintigraphic evaluation of the ischemically damaged myocardium in patients with reduced left ventricular function. From clinical aspects to the cell].
    Schwaiger M; Egert S; Brosius F
    Z Kardiol; 1995; 84 Suppl 4():115-23. PubMed ID: 8585263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thallium scintigraphy for determining myocardial vitality. Evaluation of the "stunned and hibernating myocardium"].
    Nienaber CA; Carnarius H
    Herz; 1994 Feb; 19(1):7-18. PubMed ID: 8150416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of viable myocardium: current goal in ischemic heart disease with ventricular dysfunction].
    Marin-Neto JA; Bonow RO
    Arq Bras Cardiol; 1991 Jul; 57(1):1-3. PubMed ID: 1823754
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of thallium scintigraphy and positron emission tomography.
    Niemeyer MG; Kuijper AF; Meeder JG; Cramer MJ; Cleophas AJ; van der Wall EE
    Angiology; 1997 Oct; 48(10):843-53. PubMed ID: 9342963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.
    Marshall RC; Tillisch JH; Phelps ME; Huang SC; Carson R; Henze E; Schelbert HR
    Circulation; 1983 Apr; 67(4):766-78. PubMed ID: 6600659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography.
    Schwaiger M; Brunken R; Grover-McKay M; Krivokapich J; Child J; Tillisch JH; Phelps ME; Schelbert HR
    J Am Coll Cardiol; 1986 Oct; 8(4):800-8. PubMed ID: 3489746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic imaging to assess myocardial viability.
    Schelbert HR
    J Nucl Med; 1994 Apr; 35(4 Suppl):8S-14S. PubMed ID: 8151415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thallium 201 for assessment of myocardial viability.
    Bonow RO; Dilsizian V
    Semin Nucl Med; 1991 Jul; 21(3):230-41. PubMed ID: 1948113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ischemic myocardial injury evaluated using positron emission tomography in children with coronary artery disease: comparison with thallium-201 SPECT].
    Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Yonekura Y; Yamashita K; Konishi J; Ban T; Mikawa H
    J Cardiol; 1992; 22(1):21-6. PubMed ID: 1307567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of regional myocardial blood flow and energy metabolism].
    Yonekura Y; Senda M; Torizuka K
    J Cardiol Suppl; 1987; 15():65-9. PubMed ID: 3509973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-deoxyglucose and the assessment of myocardial viability.
    Schelbert HR
    Semin Nucl Med; 2002 Jan; 32(1):60-9. PubMed ID: 11839071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography in human myocardial ischemia.
    Schelbert HR; Schwaiger M
    Herz; 1987 Feb; 12(1):22-40. PubMed ID: 3493961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET detection of viable tissue in myocardial segments with persistent defects at T1-201 SPECT.
    Brunken RC; Kottou S; Nienaber CA; Schwaiger M; Ratib OM; Phelps ME; Schelbert HR
    Radiology; 1989 Jul; 172(1):65-73. PubMed ID: 2787037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positron-emission tomography (PET) in the evaluation of metabolic processes in the myocardium].
    Haubold-Reuter B; Haldemann R; Amann F; Turina J; Reist W; Leenders K; von Schulthess GK
    Schweiz Med Wochenschr; 1992 Jan; 122(1-2):14-21. PubMed ID: 1594901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hibernation and myocardial ischemia: clinical detection by positron emission tomography.
    Uren NG; Camici PG
    Cardiovasc Drugs Ther; 1992 Jun; 6(3):273-9. PubMed ID: 1637733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Positron emission tomography: principles and uses in cardiology].
    Porenta G; Czernin J; Schelbert H
    Wien Med Wochenschr; 1992; 142(15-16):358-66. PubMed ID: 1481541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation between myocardial perfusion, myocardial necrosis and residual glucose metabolism as a vitality parameter in the post-ischemic myocardium following coronary reperfusion].
    Sochor H
    Acta Med Austriaca Suppl; 1989; 39():1-36. PubMed ID: 2787948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.